AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zucomet GP 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Zuciya Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Zucomet GP 1mg/500mg Tablet SR

DiabetaComb 1mg/500mg Extended-Release Tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are pivotal in diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Zucomet GP 1mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Zucomet GP 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Zucomet GP 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Zucomet GP 1mg/500mg Tablet SR with a meal.

Common Side effects of Zucomet GP 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Zucomet GP 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Zucomet GP 1mg/500mg Extended-Release Tablet with food.

How Zucomet GP 1mg/500mg Tablet SR works:

Zucomet GP SR tablets (1mg/500mg) combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates insulin release from the pancreas, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Zucomet GP 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zucomet GP 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Zucomet GP 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.

KidneyKidneyCAUTION

Exercise caution when prescribing Zucomet GP 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Zucomet GP 1mg/500mg SR tablets. Physician consultation is recommended. Close monitoring of renal function is advised during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Zucomet GP 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Zucomet GP 1mg/500mg Tablet SR :

Should you forget a Zucomet GP 1mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zucomet GP 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zucomet GP 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Zucomet GP 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Zucomet GP 1mg/500mg Tablet SR and seek immediate medical attention.
Zucomet GP 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Zucomet GP 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Zucomet GP 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zucomet GP 1mg/500mg Tablet SR can indeed cause hypoglycemia (low blood sugar). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Zucomet GP 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Zucomet GP 1mg/500mg Tabl...
48
MRP 55
12% off